Significant decline in subarachnoid hemorrhage hospitalizations due to COVID-19

New research led by investigators from Boston Medical Center and Grady Memorial Hospital demonstrates the significant decline in hospitalizations for neurological emergencies during the COVID-19 pandemic. The rate of Subarachnoid hemorrhage (SAH) – bleeding in the space between the brain and the tissue covering the brain – hospitalizations declined 22.5 percent during the study period,…

Study identifies possible COVID-19 drugs — including several that are FDA-approved

PHILADELPHIA – A team led by scientists in the Perelman School of Medicine at the University of Pennsylvania has identified nine potential new COVID-19 treatments, including three that are already approved by the Food and Drug Administration (FDA) for treating other diseases. The team, whose findings were published in Cell Reports, screened thousands of existing…

Cannabis use disorder linked to increased complications after spinal surgery

April 2, 2021 – For patients undergoing spinal surgery, the diagnosis of cannabis use disorder is associated with higher complication rates, including substantially increased risks of stroke and respiratory complications, reports a study in Spine. The journal is published in the Lippincott portfolio by Wolters Kluwer. “Chronic cannabis use among patients undergoing spine surgery is…